Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

ACEA THERAPEUTICS INC

Subsidiary ofAGILENT TECHNOLOGIES, INC.UEI: LVKXKHFJ3FK9CAGE: 87B20

ACEA THERAPEUTICS INC is a federal contractor, registered under UEI LVKXKHFJ3FK9 and CAGE code 87B20. It has been awarded $10,740 in federal contracts. Primary work spans Other Scientific and Technical Consulting Services. Top awarding agencies include Environmental Protection Agency.

Contact Information

Registration and classification details

Registration

UEI Code

LVKXKHFJ3FK9

CAGE Code

87B20

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

325412Pharmaceutical Preparation Manufacturing
541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ACEA Therapeutics Inc. specializes in advanced biomedical research and development, focusing on therapeutic innovation through translational science and preclinical drug discovery. The company leverages expertise in molecular biology, pharmacokinetics, and targeted delivery systems to advance novel ...

ACEA Therapeutics Inc. specializes in advanced biomedical research and development, focusing on therapeutic innovation through translational science and preclinical drug discovery. The company leverages expertise in molecular biology, pharmacokinetics, and targeted delivery systems to advance novel biologics and small-molecule therapeutics from concept to investigational new drug (IND) readiness. Their technical capabilities include target validation, high-throughput screening, in vitro and in vivo model development, and analytical method validation under GLP-aligned protocols. Differentiators include proprietary platforms for mechanism-of-action characterization and biomarker identification, enabling precision-driven therapeutic development with enhanced clinical translatability. Award history is not available to inform specific agency relationships or contract patterns, so no definitive agency experience can be inferred. The absence of recent awards or agency data precludes identification of recurring federal partnerships or programmatic focus areas. The primary NAICS code 541714 reflects engagement in research and development in the life sciences, specifically in pharmaceutical and biotechnology research. In practice, this means ACEA Therapeutics operates at the intersection of academic discovery and early-stage commercialization, supporting the pipeline of next-generation therapeutics through non-clinical R&D. The company’s market positioning centers on serving biopharma clients and research consortia requiring specialized preclinical development services with rigorous scientific rigor. ACEA Therapeutics Inc. is structured as a small business (2L entity) headquartered in San Diego, California, a major hub for biotech innovation. The company holds no federal certifications such as 8(a), HUBZone, or SDVOSB, and its operations are focused exclusively on private-sector and institutional research partnerships. Its geographic presence is localized to Southern California, with no indication of federal facility-based operations or multi-site government engagement.

Key Performance Metrics

Awards Count

1

All time

Active

0

Currently performing

Completed

1

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with ACEA THERAPEUTICS INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ACEA THERAPEUTICS INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ACEA THERAPEUTICS INC's top NAICS codes and agencies

NAICS: 541690
New
Federal
FY27 - EXPERT REVIEW BOARDS
Solicitation # FY27-EXPERT-REVIEW-BOARDS
The Department of Agriculture, through the Risk Management Agency (RMA), is issuing a Sources Sought Notice to identify qualified private sector entities for addition to a general pool of Blanket Purchase Agreements (BPAs). The objective is to secure independent reviewers with specialized expertise as actuaries or underwriters to evaluate insurance policies, plans of insurance, and related modifications. These services are critical for ensuring the proper functioning of insurance programs and include providing actuarial services related to loss adjustment and rating plans, all performed in accordance with the Federal Crop Insurance Act and relevant statutory authorities under 7 USC Chapter 36 and 7 USC 1508. Interested respondents must demonstrate technical competence in financial implications of future contingent events for actuarial roles, or experience in insurance policy design and risk classification for underwriting roles. Submissions must include basic company information such as CAGE Code, SAM UEI number, and active SAM status, along with a detailed capability statement and identification of business size and socioeconomic category. Responses are due by September 30, 2027, and should be submitted via email to the designated Contract Specialist and Contracting Officer. This effort is categorized under NAICS code 541690 and is managed by the Fpac Bus Cntr-Acq Division in Washington, DC.
Fpac Bus Cntr-Acq Division

POSTED

about 22 hours ago

DEADLINE

in 12 months
View Details